Trends in coagulation defects related mortality in adults in the United States - a retrospective analysis from 1999-2023.

A Amna Amjad (4Fatima Memorial Hospital and College of Medicine, Lahore, Lahore, Pakistan) A Abdullah Bin Usman (1Medical University Sofia, Sofia, Sofia, Bulgaria) A Aditi Parulkar (3One Brooklyn Health, New York, United States) N Nayanika Tummala (3NYMC St Marys St Clares, New Jersey, United States) R Rithish Nimmagadda (5One Brooklyn Health, Department of Internal Medicine, New York City, United States) A Abdullah Hameed (7Sahiwal Medical College, Sahiwal, Sahiwal, Pakistan) A Arooba Usman (4University College of Medicine and Dentistry, Lahore, Pakistan) H Hakim Wazir (7Lady Reading Hospital, Peshawar, Peshawar, Pakistan) A Amulya Bellamkonda (8Brookdale Hospital Medical Center- One brooklyn Health, Department of Hematology-Oncology, New York City, United States) T Tejaswi Venigalla (9Jefferson Einstein Philadelphia Hospital, Department of Hematology-Oncology, Philadelphia, United States) V Venkateswarlu Chintagumpala (Drexel University, CLAYMONT, Delaware, United States)

Abstract

Abstract Introduction: Coagulation disorders represent a heterogeneous group of conditions characterized by impaired hemostatic function, ranging from inherited bleeding disorders to acquired coagulopathies. Coagulation defects constitute a significant health concern in the United States, affecting hundreds of thousands of individuals and contributing substantially to morbidity and mortality. Objective: Trends and regional variations in U.S. mortality from 1999-2023 were analyzed in correlation to coagulation defects. Methods: The CDC WONDER database (1999–2023) was utilized to examine age-adjusted mortality rates (AAMR) and annual percent change (APC) among U.S. adults aged 65 and older with MCD - ICD-10 Codes: D65-D69 (Coagulation defects, purpura and other haemorrhagic conditions). Joinpoint regression was used for trend analysis, with data stratified on the basis of sex, race, state, place of death, and census region. Results: From 1999 to 2023, a total of 418,395 deaths related to coagulation defects were reported among older adults aged 25 and above. Overall, the age-adjusted mortality rate (AAMR) decreased from 7.89 per 100,000 population in 1999 to 7.26 in 2018 (APC: [-0.48; 95% CI: -0.30 to -0.66]), followed by a significant rise from 7.26 in 2018 to 10.03 in 2021 (APC: [12.64; 95% CI: 6.71 to 18.90]). And, dropped again in 2023 to 8.58 [APC:-5.82; 95%: -10.60 to -0.80]. Older men had a higher AAMR compared to older women (8.52 vs. 6.36), with respective APCs of 0.45 [95% CI: -0.50 to 0.45] for men and 0.66 [95% CI: -0.05 to 1.38] for women. Among racial and ethnic groups, African Americans had the highest AAMR (10.31). Regionally, the South reported the highest AAMR (7.88). Micropolitan (non-metropolitan) areas had a higher AAMR (7.94) compared to large metropolitan areas (7.41). State-level AAMRs ranged from 5.42 in Illinois to 15.04 in South Dakota. States in the top 90th percentile included North Dakota (12.93), South Carolina (13.36), Colorado (13.37), and Wyoming (12.82) with rates approximately double those in the bottom 10th percentile. Notably, mortality was more frequent in medical facilities (69.62%) than at home (14.51%). Conclusion: Overall, US adults aged 25 and more saw a modest decline in mortality secondary to coagulation defects mortality from 1999 to 2018, a sharp rise during 2018–2021, and a subsequent drop by 2023. Persistent disparities—higher rates in men, African Americans, and in the South and micropolitan areas—alongside most deaths in medical facilities, sheds light on the need for targeted public health interventions.

Article Details

Journal Blood
Volume / Issue Vol. 146, Issue Supplement 1
Published November 03, 2025
Pages 3087-3087
ISSN 0006-4971
Publisher Elsevier BV

Journal Info

Blood

Elsevier BV

ISSN: 0006-4971 Health Sciences

Authors (11)

A

Amna Amjad

4Fatima Memorial Hospital and College of Medicine, Lahore, Lahore, Pakistan

A

Abdullah Bin Usman

1Medical University Sofia, Sofia, Sofia, Bulgaria

A

Aditi Parulkar

3One Brooklyn Health, New York, United States

N

Nayanika Tummala

3NYMC St Marys St Clares, New Jersey, United States

R

Rithish Nimmagadda

5One Brooklyn Health, Department of Internal Medicine, New York City, United States

A

Abdullah Hameed

7Sahiwal Medical College, Sahiwal, Sahiwal, Pakistan

A

Arooba Usman

4University College of Medicine and Dentistry, Lahore, Pakistan

H

Hakim Wazir

7Lady Reading Hospital, Peshawar, Peshawar, Pakistan

A

Amulya Bellamkonda

8Brookdale Hospital Medical Center- One brooklyn Health, Department of Hematology-Oncology, New York City, United States

T

Tejaswi Venigalla

9Jefferson Einstein Philadelphia Hospital, Department of Hematology-Oncology, Philadelphia, United States

V

Venkateswarlu Chintagumpala

Drexel University, CLAYMONT, Delaware, United States